Ledger.Open graph →
SEC Form D · filed March 14, 2014

T3D Therapeutics, Inc

Offering
$2.5M
Sold
$661K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
RESEARCH TRIANGLE PARK, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Barry Buzogany · Research Triangle Park, NCDirectorCharles Lineberry · Research Triangle Park, NCDirectorJohn Didsbury · Research Triangle Park, NCExec · DirectorCharles G. Koch · Wichita, KSDirectorJames B. Hannan · Wichita, KSExec · DirectorRandall A. Bushman · Wichita, KSDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗